Is Agilent Technologies, Inc. (A) a Buy, Sell, or Hold?
Agilent Technologies, Inc.
NYSE:A
$135.2 USD
$1.16 (0.87%)
- Volume
- 1.68M
- Average Volume
- 2.38M
- Market Capitalization
- $38.18B
- P/E Ratio
- 27.09
- Dividend Yield
- 0.75%
- Price Target
- $152.50
- Year High
- $160.27
- Year Low
- $108.35
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.20
- Current Ratio
- $2.10
Industry, Sector & symbol
| Stock Exchange | NYSE |
| CEO | Padraig McDonnell |
| Industry | Medical - Diagnostics & Research |
| Sector | Healthcare |
| Current Symbol | A |
| CUSIP | 00846U101 |
| CIK | 0001090872 |
| Web | https://www.agilent.com |
| Phone | 800 227 9770 |
| Currency | USD |
| Employees | 18100 |
| Country | US |
Liquidity
| Debt-to-Equity Ratio | 0.47 |
| Payout Ratio | 0.20 |
| Current Ratio | 2.10 |
| Quick Ratio | 1.62 |
| Cash Ratio | 0.80 |
Sales & Book Value
| Annual Sales | $6.95B |
| Price / Sales | 5.28 |
| Cash Flow | 4.44 |
| Price / Cash Flow | 30.40 |
| Price / Book | 5.37 |
Price Target and Rating
| Average Stock Price Forecast | $152.50 |
| High Stock Price Forecast | $165.00 |
| Low Stock Price Forecast | $140.00 |
| Forecast Upside/Downside | -11.34% |
| Consensus Rating | Buy |
| Rating Score(0-5) | 4 |
| Research Coverage | 41 Analysts |
Profitability
| EPS (Most Recent Fiscal Year) | $4.57 |
| Trailing P/E Ratio | 27.09 |
| PEG Ratio | 1.20 |
| P/E Growth | 1.20 |
| Net Income | $1.3B |
| Net Margin | 19.55% |
| Pretax Margin | 21.85% |
| Return on Equity | 20.84% |
| Return on Assets | 10.82% |
Financials Score
| AltmanZ Score | 5.21 |
| Piotroski Score | 9.00 |
| Working Capital | 2.49B |
| Total Assets | 13.06B |
| Ebit | 1.68B |
| Market Cap | 37.86B |
| Total Liabilities | 5.94B |
Poll Results
About Agilent Technologies, Inc. (NYSE:A) Stock
Agilent Technologies, Inc. delivers specialized, application-focused technologies and services to the global life sciences, diagnostics, and applied chemistry industries. Its Life Sciences and Applied Markets segment provides a comprehensive portfolio of analytical instrumentation. This includes liquid chromatography (LC) and gas chromatography (GC) systems, often integrated with mass spectrometry (MS) for advanced analysis (LC-MS, GC-MS). They also offer inductively coupled plasma mass spectrometry (ICP-MS), atomic absorption (AA), microwave plasma-atomic emission spectrometry (MP-AES), and inductively coupled plasma optical emission spectrometry (ICP-OES) instruments, alongside Raman spectroscopy for material characterization. Beyond spectroscopy, the segment supplies cell analysis solut ... ions such as plate-based assays, flow cytometers, real-time cell analyzers, imaging systems, and microplate readers. Complementing these are various laboratory software, information management platforms, data analytics tools, automated and robotic lab systems, dissolution testing equipment, vacuum technology, and general measurement solutions. The Diagnostics and Genomics division offers cutting-edge tools for genetic and diagnostic research. These encompass arrays designed for DNA mutation detection, genotyping, gene copy number determination, identification of gene rearrangements, DNA methylation profiling, and gene expression analysis. This segment also provides target enrichment solutions for next-generation sequencing, along with software for genetic data management and interpretation. Furthermore, it synthesizes custom oligonucleotides. Other significant offerings include immunohistochemistry (IHC), in situ hybridization (ISH), hematoxylin and eosin (H&E) staining, and specialized staining solutions. The division also supplies consumables and software essential for quality control analysis of nucleic acid samples, as well as reagents for turbidimetry and flow cytometry applications. A key area of development for this segment is liquid-based pharmacodiagnostics. Agilent CrossLab, the third segment, focuses on providing essential laboratory consumables and services. Its product range features GC and LC columns, products for sample preparation, custom chemical formulations, and various supplies for laboratory instruments. Complementary services include expert support for startup, ongoing operations, training, compliance, Software-as-a-Service (SaaS) offerings, asset management, and professional consultation. The company's products reach customers through a diverse sales network, including direct sales teams, distributors, resellers, manufacturer's representatives, and its e-commerce platforms. Agilent Technologies, Inc. was established in 1999 and maintains its corporate headquarters in Santa Clara, California.
Agilent Strengthens Biopharma Growth Prospects With AI Expansion
2026-07-09 14:55:16
A enhances AI-powered lab software, automation and digital workflows to support drug discovery, biopharma research and long-term growth.
2026-07-08 08:00:00
SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced the latest expansion of its Altura HPLC column portfolio with the introduction of Altura size exclusion chromatography (SEC) and Altura PLRP-S columns, designed to support critical analytical workflows in biopharmaceutical development and production.The new SEC and PLRP-S columns support critical analytical workflows across a range of biotherapeutic modalities, including peptides, proteins, oligonucleotides.
Alpha and Omega Semiconductor Unveils AmpStack™ Packaging: A Leap Forward in MOSFET Power Density
2026-07-07 11:00:00
[url="]Alpha and Omega Semiconductor Limited[/url] (AOS) (Nasdaq: AOSL), a designer, developer, and global supplier of a broad range of discrete power devices,
Agilent Launches AI-Driven Analysis Module for Agilent xCELLigence RTCA eSight
2026-07-01 08:00:00
SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced the launch of Agilent xCELLigence RTCA eSight AI, a new AI-powered software module that simplifies label-free imaging analysis by reducing manual cell segmentation steps and parameter tuning and supporting more consistent results. The software upgrade enhances the unique dual-readout capabilities of the Agilent xCELLigence RTCA eSight instrument with AI-driven cell imaging analysis, enabling researchers to.
Why Is Agilent (A) Up 0.1% Since Last Earnings Report?
2026-06-26 12:31:14
Agilent (A) reported earnings 30 days ago. What's next for the stock?
Excellere Partners and GHO Capital complete sale of Biocare Medical to Agilent Technologies
2026-06-25 08:06:00
Denver, CO and London, UK – 25 June 2026: Excellere Partners (“Excellere”), a Denver-based private equity firm specializing in partnering with entrepreneurs and management teams, and GHO Capital Partners LLP (“GHO”), a specialist investor in global healthcare, today announced the completion of the sale of Biocare Medical ("Biocare"), a global leader in immunohistochemistry (IHC), in situ hybridization (ISH) and fluorescence in situ hybridization (FISH) solutions, to Agilent Technologies, Inc. ("Agilent", NYSE:A).
Agilent Completes Acquisition of Biocare Medical
2026-06-25 08:00:00
SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced the successful completion of its previously announced acquisition of Biocare Medical, a global leader in clinical pathology, from an investor group led by Excellere Partners and GHO Capital Partners LLP. Following the close of the transaction, Biocare is now part of Agilent's Life Sciences and Diagnostics Markets Group.“We are pleased to complete our acquisition of Biocare, which represents a natural and st.
Canadian Apartment REIT: A 4.5% Dividend Yield With Ample Coverage
2026-06-24 10:30:00
Canadian Apartment Properties REIT trades at 15x AFFO and nearly 40% below NAV, offering compelling value. Q1 AFFO per share declined just 1.5% to C$0.513, with a strong 70% payout ratio and robust distribution coverage. Active buybacks and retained AFFO (~C$100 million/year) support growth initiatives and the development pipeline.
Frequently Asked Questions
-
What is the current Agilent Technologies, Inc. (A) stock price?
-
Agilent Technologies, Inc.(NYSE:A) stock price is $135.2 in the last trading session. During the trading session, A stock reached the peak price of $160.27 while $108.35 was the lowest point it dropped to. The percentage change in A stock occurred in the recent session was 0.87% while the dollar amount for the price change in A stock was $1.16.
-
A's industry and sector of operation?
-
The NYSE listed A is part of Medical - Diagnostics & Research industry that operates in the broader Healthcare sector.
-
Who are the executives of A?
-
Rodney Gonsalves | Vice President of Finance
Tim Downs | VP & Chief Accounting Officer
Yvonne Mackie | MD of UK & Ireland Operations and Vice President of Human Resources - Europe
Angelica Riemann | Senior VP & President of Agilent CrossLab Group
Frederick Schwarz | Senior VP, Chief Strategy & Corporate Development Officer -
How many employees does A have?
-
Number of A employees currently stands at 18100. A operates from 5301 Stevens Creek Boulevard, Santa Clara, CA 95051, US.
-
Link for A official website?
-
Official Website of A is: https://www.agilent.com
-
How do I contact A?
-
A could be contacted at phone #800 227 9770 and can also be accessed through its website. A operates from 5301 Stevens Creek Boulevard, Santa Clara, CA 95051, US.
-
How many shares of A are traded daily?
-
The average number of A shares traded daily for last 3 months was 2.38M.
-
What is the market cap of A currently?
-
The market value of A currently stands at $38.18B with its latest stock price at $135.2